CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 265 filers reported holding CONMED CORP in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $346,970,290 | -25.8% | 3,440,459 | -0.0% | 0.01% | -18.2% |
Q2 2023 | $467,562,159 | +30.4% | 3,440,740 | -0.4% | 0.01% | +22.2% |
Q1 2023 | $358,694,428 | +18.2% | 3,453,634 | +0.9% | 0.01% | +12.5% |
Q4 2022 | $303,458,863 | +13.4% | 3,423,498 | +2.5% | 0.01% | 0.0% |
Q3 2022 | $267,654,000 | -12.9% | 3,338,586 | +4.0% | 0.01% | -11.1% |
Q2 2022 | $307,459,000 | -35.1% | 3,210,729 | +0.7% | 0.01% | -18.2% |
Q1 2022 | $473,678,000 | +5.5% | 3,188,672 | +0.6% | 0.01% | +10.0% |
Q4 2021 | $449,187,000 | +8.7% | 3,168,648 | +0.3% | 0.01% | 0.0% |
Q3 2021 | $413,176,000 | -4.5% | 3,158,108 | +0.3% | 0.01% | -9.1% |
Q2 2021 | $432,863,000 | +6.3% | 3,149,699 | +1.0% | 0.01% | 0.0% |
Q1 2021 | $407,067,000 | +21.1% | 3,117,131 | +3.8% | 0.01% | +10.0% |
Q4 2020 | $336,267,000 | +46.3% | 3,002,388 | +2.8% | 0.01% | +25.0% |
Q3 2020 | $229,838,000 | +4.9% | 2,921,543 | -4.0% | 0.01% | 0.0% |
Q2 2020 | $219,087,000 | +25.2% | 3,043,288 | -0.4% | 0.01% | +14.3% |
Q1 2020 | $175,047,000 | -47.8% | 3,056,519 | +1.9% | 0.01% | -36.4% |
Q4 2019 | $335,501,000 | +19.2% | 3,000,096 | +2.5% | 0.01% | +10.0% |
Q3 2019 | $281,410,000 | +14.6% | 2,926,781 | +2.0% | 0.01% | +11.1% |
Q2 2019 | $245,554,000 | +6.6% | 2,869,620 | +3.6% | 0.01% | 0.0% |
Q1 2019 | $230,312,000 | +30.0% | 2,768,841 | +0.3% | 0.01% | +12.5% |
Q4 2018 | $177,170,000 | -16.1% | 2,759,658 | +3.5% | 0.01% | 0.0% |
Q3 2018 | $211,262,000 | +14.8% | 2,666,773 | +6.1% | 0.01% | 0.0% |
Q2 2018 | $183,980,000 | +20.5% | 2,513,377 | +4.2% | 0.01% | +14.3% |
Q1 2018 | $152,722,000 | +29.1% | 2,411,545 | +3.9% | 0.01% | +40.0% |
Q4 2017 | $118,291,000 | -3.8% | 2,320,809 | -1.0% | 0.01% | -16.7% |
Q3 2017 | $122,973,000 | +5.2% | 2,343,684 | +2.1% | 0.01% | 0.0% |
Q2 2017 | $116,875,000 | +16.0% | 2,294,366 | +1.1% | 0.01% | +20.0% |
Q1 2017 | $100,761,000 | +4.4% | 2,268,882 | +3.9% | 0.01% | 0.0% |
Q4 2016 | $96,471,000 | +12.9% | 2,184,097 | +2.4% | 0.01% | 0.0% |
Q3 2016 | $85,452,000 | -13.9% | 2,133,099 | +2.6% | 0.01% | -16.7% |
Q2 2016 | $99,207,000 | +12.4% | 2,078,518 | -1.3% | 0.01% | 0.0% |
Q1 2016 | $88,280,000 | +6.0% | 2,104,909 | +11.3% | 0.01% | 0.0% |
Q4 2015 | $83,321,000 | -83.2% | 1,891,504 | -85.0% | 0.01% | -66.7% |
Q3 2015 | $494,926,000 | +360.2% | 12,578,281 | +581.4% | 0.02% | +157.1% |
Q2 2015 | $107,557,000 | +18.9% | 1,845,857 | +3.0% | 0.01% | +16.7% |
Q1 2015 | $90,464,000 | +18.5% | 1,791,744 | +5.5% | 0.01% | +20.0% |
Q4 2014 | $76,348,000 | +24.7% | 1,698,142 | +2.2% | 0.01% | 0.0% |
Q3 2014 | $61,207,000 | -15.0% | 1,661,431 | +1.9% | 0.01% | -16.7% |
Q2 2014 | $72,007,000 | -4.2% | 1,630,973 | -5.7% | 0.01% | 0.0% |
Q1 2014 | $75,134,000 | +5.2% | 1,729,200 | +2.9% | 0.01% | 0.0% |
Q4 2013 | $71,409,000 | +28.7% | 1,680,206 | +2.9% | 0.01% | +20.0% |
Q3 2013 | $55,492,000 | +10.2% | 1,632,614 | +1.3% | 0.01% | 0.0% |
Q2 2013 | $50,351,000 | – | 1,611,743 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |